This HuGEMM model consist of chimeric PD-1 and CTLA-4, which is an appropriate platform for testing the combination of human anti-PD-1 and human anti-CTLA-4 antibody evaluation.
| Summary | |
|---|---|
| Cancer Type | N/A |
| Type | Double Knock-In |
| Target | Human PD-1/CTLA4 |
| Mouse Strain | C57BL/6 |
